celecoxib has been researched along with mocetinostat in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (63.16) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Ajuebor, MN; Singh, A; Wallace, JL | 1 |
| Oberyszyn, TM; Parrett, ML; Ross, MS; Wilgus, TA | 1 |
| Caputi, AP; Centorrino, T; Ciccolo, A; Cuzzocrea, S; Dugo, L; Mazzon, E; Sautebin, L; Serraino, I | 1 |
| Calixto, JB; Pinheiro, RM | 1 |
| Jain, NK; Kulkarni, SK; Patil, CS; Singh, VP | 1 |
| Cho, YB; Han, CK; Joo, HJ; Jung, IH; Jung, K; Kim, JH; Kwak, WJ; Rhee, HI; Ryu, K | 1 |
| Alhan, E; Ercin, C; Kalyoncu, NI; Kural, BV | 1 |
| Gautam, P; Poonam, D; Vinay, CS | 1 |
| Bertini, S; Bonardi, S; Coruzzi, G; Giovannini, E; Grandi, D; Menozzi, A; Pozzoli, C; Solenghi, E; Vasina, V | 1 |
| Aoi, Y; Hayashi, S; Kato, S; Nishio, H; Okayama, M; Takeuchi, K | 1 |
| Batu, OS; Erol, K | 1 |
| Caliari, MV; de Francischi, JN; Fonseca, AH; Klein, A; Pacheco, CM; Queiroz-Junior, CM | 1 |
| Brzozowski, T; Drozdowicz, D; Karczewska, E; Konturek, SJ; Krzysiek-Maczka, G; Pajdo, R; Pawlik, WW; Ptak-Belowska, A; Sliwowski, Z; Urbanczyk, K; Zwolinska-Wcislo, M | 1 |
| Bandyopadhyay, SK; Chatterjee, A; Chatterjee, S; Chattopadhyay, S; Das, S; Saha, A | 1 |
| Brorson, SH; Egner, I; Koskinen, S; Lauritzen, F; Owe, S; Paulsen, G; Raastad, T; Reinholt, F | 1 |
| Dong, L; Jurban, BJ; Sharma, NP; Smith, WL | 1 |
| Dandekar, P; Gugulothu, D; Kulkarni, A; Patravale, V | 1 |
| Abdelsalam, RM; Arab, HH; Darwish, HA | 1 |
1 trial(s) available for celecoxib and mocetinostat
| Article | Year |
|---|---|
Inflammatory markers CD11b, CD16, CD66b, CD68, myeloperoxidase and neutrophil elastase in eccentric exercised human skeletal muscles.
Topics: Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; CD11b Antigen; Celecoxib; Cell Adhesion Molecules; Cyclooxygenase 2 Inhibitors; Exercise; Female; GPI-Linked Proteins; Humans; Inflammation; Leukocyte Elastase; Male; Muscle Contraction; Muscle, Skeletal; Peroxidase; Pyrazoles; Receptors, IgG; Sulfonamides | 2013 |
18 other study(ies) available for celecoxib and mocetinostat
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Cyclooxygenase-2-derived prostaglandin D(2) is an early anti-inflammatory signal in experimental colitis.
Topics: Animals; Blotting, Western; Celecoxib; Colitis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Gene Expression Regulation, Enzymologic; Hydantoins; Indomethacin; Intramolecular Oxidoreductases; Isoenzymes; Lipocalins; Male; Necrosis; Neutrophils; Peroxidase; Peroxisomes; Prostaglandin D2; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Prostaglandin; RNA, Messenger; Sulfonamides; Transcription Factors | 2000 |
Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation.
Topics: Administration, Topical; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dermatitis; Dinoprostone; Edema; Epidermis; Female; Ibuprofen; Isoenzymes; Mice; Mice, Hairless; Neutrophils; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Skin; Sulfonamides; Sunburn; Ultraviolet Rays | 2000 |
Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzenesulfonates; Body Weight; Celecoxib; Colitis; Colon; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Immunohistochemistry; Intercellular Adhesion Molecule-1; Isoenzymes; Lipid Peroxidation; Male; Neutrophils; P-Selectin; Peroxidase; Peroxynitrous Acid; Poly(ADP-ribose) Polymerases; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides | 2001 |
Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dexamethasone; Dinoprostone; Edema; Indomethacin; Inflammation; Interleukin-1; Isoenzymes; Lactones; Male; Nitric Oxide; Peroxidase; Pleurisy; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Sulfones; Thromboxane B2; Tumor Necrosis Factor-alpha | 2002 |
Aggravation of inflammatory bowel disease by cyclooxygenase-2 inhibitors in rats.
Topics: Animals; Celecoxib; Colon; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Female; Indomethacin; Inflammatory Bowel Diseases; Male; Muscle Contraction; Oxidative Stress; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Wistar; Sulfonamides | 2004 |
SKI306X, an oriental herbal mixture, suppresses gastric leukotriene B4 synthesis without causing mucosal injury and the diclofenac-induced gastric lesions.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Depression, Chemical; Diclofenac; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Eicosanoids; Gastric Mucosa; Leukotriene B4; Male; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sulfonamides | 2005 |
Effects of the celecoxib on the acute necrotizing pancreatitis in rats.
Topics: Animals; Celecoxib; Ceruletide; Cyclooxygenase Inhibitors; Disease Models, Animal; Edema; Glycodeoxycholic Acid; Inflammation; Interleukin-6; Lung; Male; Malondialdehyde; Multiple Organ Failure; Pancreas; Pancreatitis, Acute Necrotizing; Peroxidase; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Survival Analysis; Urea; Urine | 2004 |
Cyclo-oxygenase-2 expression and prostaglandin E2 production in experimental chronic gastric ulcer healing.
Topics: Animals; Anti-Ulcer Agents; Blotting, Western; Celecoxib; Chronic Disease; Cyclooxygenase 2; Dinoprostone; Female; Gastric Mucosa; Male; Misoprostol; Omeprazole; Peroxidase; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Sulfonamides; Wound Healing | 2005 |
Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
Topics: Administration, Oral; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Enterobacteriaceae; Ibuprofen; Indomethacin; Intestinal Mucosa; Intestine, Small; Lipid Peroxidation; Male; Mucins; Peroxidase; Pyrazoles; Rats; Rats, Wistar; Sulfonamides | 2006 |
Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats.
Topics: Animals; Cardiovascular Diseases; Celecoxib; Colitis, Ulcerative; Colon; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dextran Sulfate; Dinoprostone; Disease Models, Animal; Gene Expression; Indomethacin; Male; Peroxidase; Plasma Substitutes; Pyrazoles; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrophotometry; Sulfonamides; Treatment Outcome | 2007 |
The effects of some nonsteroidal anti-inflammatory drugs on experimental induced gastric ulcers in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Dinoprostone; Dipyrone; Ditiocarb; Gastric Acidity Determination; Gastric Mucosa; Histamine; Lipid Peroxides; Male; Malondialdehyde; Mucus; Peroxidase; Pyrazoles; Rats; Stomach Ulcer; Stress, Psychological; Sulfhydryl Compounds; Sulfonamides | 2007 |
Myeloperoxidase content is a marker of systemic inflammation in a chronic condition: the example given by the periodontal disease in rats.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Celecoxib; Inflammation; Leukocyte Count; Male; Morphine; Neutrophils; Periodontal Diseases; Peroxidase; Pyrazoles; Rats; Sulfonamides | 2009 |
Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bacterial Load; Bacterial Translocation; Celecoxib; Chemokines; Colitis; Colon; Cyclooxygenase 2 Inhibitors; Enterococcus; Escherichia coli; Feces; Humans; Intestinal Mucosa; Intestines; Male; Microcirculation; Peroxidase; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Trinitrobenzenesulfonic Acid | 2011 |
Ellagic acid facilitates indomethacin-induced gastric ulcer healing via COX-2 up-regulation.
Topics: Animals; Blotting, Western; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Cytokines; Dinoprostone; Dose-Response Relationship, Drug; Ellagic Acid; Enzyme-Linked Immunosorbent Assay; Gastric Mucosa; Indomethacin; Intercellular Signaling Peptides and Proteins; Male; Mice; Molecular Structure; Nitrobenzenes; Peroxidase; Pyrazoles; Stomach Ulcer; Sulfonamides; Time Factors; Up-Regulation; Wound Healing | 2012 |
Pre-existent asymmetry in the human cyclooxygenase-2 sequence homodimer.
Topics: Acetylation; Amino Acid Sequence; Amino Acid Substitution; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Flurbiprofen; Guanidine; Heme; Humans; Indomethacin; Kinetics; Models, Biological; Mutant Proteins; Mutation; Naproxen; Oxygen; Palmitic Acid; Peroxidase; Protein Multimerization; Pyrazoles; Substrate Specificity; Sulfonamides | 2013 |
pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
Topics: Algorithms; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Celecoxib; Colitis, Ulcerative; Colon; Curcumin; Cyclooxygenase 2 Inhibitors; Drug Combinations; Drug Compounding; Drug Synergism; Electrochemistry; Excipients; Freeze Drying; Hydrogen-Ion Concentration; Lipid Peroxidation; Male; Nanoparticles; Particle Size; Peroxidase; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Superoxide Dismutase | 2014 |
Chrysin alleviates testicular dysfunction in adjuvant arthritic rats via suppression of inflammation and apoptosis: comparison with celecoxib.
Topics: Administration, Oral; Animals; Apoptosis; Arthritis, Experimental; Caspase 3; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Fas Ligand Protein; Flavonoids; Follicle Stimulating Hormone; Inflammation; Inflammation Mediators; Luteinizing Hormone; Male; Nitric Oxide Synthase Type II; Oxidative Stress; Peroxidase; Phosphoproteins; Pyrazoles; Rats; Rats, Wistar; RNA, Messenger; Spermatogenesis; Sulfonamides; Testis; Testosterone; Time Factors; Tumor Necrosis Factor-alpha | 2014 |